Vesicare and Docetaxel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vesicare (solifenacin succinate) and Docetaxel (docetaxel). Common drug interactions include alopecia among females and neuropathy peripheral among males.
The phase IV clinical study analyzes what interactions people have when they take Vesicare and Docetaxel. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.
What is Docetaxel?
Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
58 people who take Vesicare and Docetaxel together, and have interactions are studied.

What are the common drug interactions of Vesicare and Docetaxel, by gender? *:
female:
- Alopecia (absence of hair from areas of the body)
- Hair colour changes
- Hair disorder
- Diarrhoea
- Febrile neutropenia (fever with reduced white blood cells)
- Hypokalaemia (low potassium)
- Hypotension (abnormally low blood pressure)
- Interstitial lung disease
- Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
- Psychological trauma
male:
- Neuropathy peripheral (surface nerve damage)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Haematocrit decreased
- Haemoglobin decreased
- Lymphocyte count decreased
- Metastases to bone (cancer spreads to bone)
- Metastases to lymph nodes (cancer spreads to lymph node)
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
- Peroneal nerve palsy
What are the common drug interactions of Vesicare and Docetaxel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Alopecia (absence of hair from areas of the body)
- Hair colour changes
- Hair disorder
- Psychological trauma
- Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
- Lung disorder (lung disease)
- Alopecia areata (patchy baldness that typically begins with rapid hair loss)
- Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
- Grip strength decreased
- Nerve injury
60+:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Malignant melanoma (skin cancer rises from melancytes)
- Disease recurrence
- Hypotension (abnormally low blood pressure)
- Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
- Second primary malignancy (after getting cure a cancer, a new cancer development)
- Surgery
- Bronchopneumopathy
- Faecaloma (hard mass of fecal matter)
- Abdominal distension
What are the existing conditions these people have? *
- Breast Cancer Female: 15 people, 25.86%
- Prostate Cancer: 12 people, 20.69%
- Breast Cancer: 8 people, 13.79%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 6.90%
- High Blood Pressure: 4 people, 6.90%
- Constipation: 4 people, 6.90%
- Breast Cancer Metastatic: 4 people, 6.90%
- Prostate Cancer Metastatic: 3 people, 5.17%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 5.17%
- Diabetes: 3 people, 5.17%
* Approximation only. Some reports may have incomplete information.
Do you take Vesicare and Docetaxel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vesicare and Docetaxel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Docetaxel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Docetaxel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
- Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on solifenacin succinate and docetaxel (the active ingredients of Vesicare and Docetaxel, respectively), and Vesicare and Docetaxel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lamotrigine and Fluconazole - now
- Could Lipitor cause Uterine Leiomyoma? - a second ago
- Could Percocet cause Conjunctivitis Aggravated? - 8 seconds ago
- Could Tramadol Hydrochloride And Acetaminophen cause Memory Loss? - 10 seconds ago
- Could Clozapine cause Acute Febrile Neutrophilic Dermatosis? - 13 seconds ago
- Could Lipitor cause Gastrointestinal Tract Irritation? - 13 seconds ago
- Could Ethyol cause Chills? - 17 seconds ago
- Could Etomidate cause Malaise? - 18 seconds ago
- Asthma and Hypoaesthesia Eye - 25 seconds ago
- Drug interactions of Pamelor and Bystolic - 26 seconds ago